- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1756-8722
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Oncolytic viruses for cancer immunotherapy ; volume:13 ; number:1 ; day:29 ; month:6 ; year:2020 ; pages:1-15 ; date:12.2020
Journal of hematology & oncology ; 13, Heft 1 (29.6.2020), 1-15, 12.2020
- Creator
-
Hemminki, Otto
Santos, João Manuel dos
Hemminki, Akseli
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13045-020-00922-1
- URN
-
urn:nbn:de:101:1-2020082421454193753823
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.06.2025, 10:53 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Hemminki, Otto
- Santos, João Manuel dos
- Hemminki, Akseli
- SpringerLink (Online service)
Other Objects (12)
Oncolytic Viruses: Priming Time for Cancer Immunotherapy
Perspectives on immunotherapy via oncolytic viruses
Oncolytic immunotherapy: unlocking the potential of viruses to help target cancer
Oncolytic viruses as therapeutic cancer vaccines
New immunotherapy approaches for colorectal cancer: focusing on CAR-T cell, BiTE, and oncolytic viruses
BiTE-armed oncolytic measles viruses for cancer immunovirotherapy
BiTE-armed oncolytic measles viruses for cancer immunovirotherapy
Oncolytic viruses for triple negative breast cancer and beyond
Two roads for oncolytic immunotherapy development
Improving the therapeutic efficacy of oncolytic viruses for cancer: targeting macrophages
Oncolytic virus immunotherapy: future prospects for oncology
Investigating the potential of oncolytic viruses for cancer treatment via MSC delivery
Oncolytic Viruses: Priming Time for Cancer Immunotherapy
Perspectives on immunotherapy via oncolytic viruses
Oncolytic immunotherapy: unlocking the potential of viruses to help target cancer
Oncolytic viruses as therapeutic cancer vaccines
New immunotherapy approaches for colorectal cancer: focusing on CAR-T cell, BiTE, and oncolytic viruses
BiTE-armed oncolytic measles viruses for cancer immunovirotherapy
BiTE-armed oncolytic measles viruses for cancer immunovirotherapy
Oncolytic viruses for triple negative breast cancer and beyond
Two roads for oncolytic immunotherapy development
Improving the therapeutic efficacy of oncolytic viruses for cancer: targeting macrophages
Oncolytic virus immunotherapy: future prospects for oncology
Investigating the potential of oncolytic viruses for cancer treatment via MSC delivery
Oncolytic Viruses: Priming Time for Cancer Immunotherapy
Perspectives on immunotherapy via oncolytic viruses
Oncolytic immunotherapy: unlocking the potential of viruses to help target cancer
Oncolytic viruses as therapeutic cancer vaccines
New immunotherapy approaches for colorectal cancer: focusing on CAR-T cell, BiTE, and oncolytic viruses
BiTE-armed oncolytic measles viruses for cancer immunovirotherapy
BiTE-armed oncolytic measles viruses for cancer immunovirotherapy
Oncolytic viruses for triple negative breast cancer and beyond
Two roads for oncolytic immunotherapy development
Improving the therapeutic efficacy of oncolytic viruses for cancer: targeting macrophages
Oncolytic virus immunotherapy: future prospects for oncology